Liquidia Technologies Stock News & Updates

[WKN: A2JRNS | Symbol: LQDA]

Liquidia Technologies

Pivotal Point Tracking Liquidia Technologies (LQDA): Biopharma Pioneer Settled Patent Disputes - Marketing of YUTREPIA Secured

10/14/2026 at 03 PM

GameStop (GME) – Cohen buys another $22.8 million in shares: Insiders bet $99 million on the turnaround!...

10/14/2026 at 10 AM

Legal peace achieved: Liquidia ends all patent disputes with United Therapeutics through a global...

07/21/2026 at 02 PM

Liquidia utilizes its patented PRINT® platform to transform established active ingredients like Treprostinil...

05/12/2026 at 08 AM

The main product YUTREPIA grows sequentially by 44% and increased its share in a $2 billion market...

03/06/2026 at 01 PM

Renk Group [DE000RENK730] JPMorgan confirms Overweight rating and price target of €75 (35% upside...

02/03/2026 at 11 AM

Through its unique PRINT platform, Liquidia manufactures highly precise inhaled medications that are...

01/15/2026 at 11 AM

Liquidia Technologies (LQDA) is successfully transforming from a purely development company into a commercial...

11/03/2025 at 05 PM

The Liquidia Corporation (LQDA) is a biopharmaceutical company focused on the development and commercialization...

08/19/2025 at 04 PM

Liquidia Technologies impressed investors with a rapid market launch following the early approval of...

08/07/2025 at 01 PM

Liquidia Technologies [US53635D2027] LifeSci Capital confirms Buy rating with a price target...

05/27/2025 at 02 PM

Liquida Technologies [US53635D2027]: Bank of America reaffirms Buy rating and raises the price target...